Search

Displaying results 5661 - 5670 of 10000 in total
  1. Drug

    Umbralisib

    go.drugbank.com/drugs/DB14989
    ApprovedInvestigationalWithdrawn

    [A229363] Follicular lymphoma is also treated with rituximab and other chemotherapeutic agents, but may show similar progression. … Marginal zone lymphoma is a rare, slowly progressing type of non-Hodgkin lymphoma initially treated with [rituximab] (an anti-CD20 drug), either alone or in combination with chemotherapy.

  2. Drug

    Nicorandil

    go.drugbank.com/drugs/DB09220
    ApprovedInvestigationalWithdrawn

    Nicorandil is an orally efficacious vasodilatory drug and antianginal agent marketed in the UK, Australia, most of Europe, India, Philippines, Japan, South Korea, and Taiwan. … It is not an approved drug by FDA. It is a niacinamide derivative that induces vasodilation of arterioles and large coronary arteries by activating potassium channels.

  3. Drug

    AL-02

    go.drugbank.com/drugs/DB06065
    Experimental

  4. Drug

    TG1024

    go.drugbank.com/drugs/DB06180
    Experimental

  5. Drug

    Dotarizine

    go.drugbank.com/drugs/DB06446
    Experimental

  6. Drug

    Mitumomab

    go.drugbank.com/drugs/DB06462
    Experimental

    Mitumomab, an anti-BEC-2 monoclonal antibody derived from mice, was previously studied to treat small cell lung carcinoma in combination with BCG vaccination.

  7. Drug

    Ragaglitazar

    go.drugbank.com/drugs/DB06533
    Experimental

  8. Drug

    Robalzotan

    go.drugbank.com/drugs/DB06538
    Experimental

  9. Drug

    Gavilimomab

    go.drugbank.com/drugs/DB06545
    Investigational

  10. Drug

    Fispemifene

    go.drugbank.com/drugs/DB06640
    Investigational